Search
Search Results
##search.searchResults.foundPlural##
-
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1392PDF: 1055HTML: 4615 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3746PDF: 1257HTML: 3911Untitled: 239Untitled: 275 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3183PDF: 1159HTML: 1531Untitled: 183Untitled: 176Untitled: 177 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3280PDF: 931HTML: 767text and figure: 238 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2084PDF: 784HTML: 3119 -
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1579PDF: 800HTML: 1493Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 186 -
-
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2160PDF: 789HTML: 1059Spirometry in SCA patients before transplant: 214Spirometry in SCA patients post transplant: 189 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2236PDF: 1338Html: 314 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1360PDF: 1170HTML: 127 -
-
Sickle cell disease and Bartonella spp. infection
1276PDF: 974HTML: 464 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
732PDF: 558HTML: 221 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2573PDF: 960HTML: 324 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1680PDF: 1023HTML: 375 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1136PDF: 974HTML: 345 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1197PDF: 492HTML: 8190 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2468PDF: 1613HTML: 664 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2176PDF: 514HTML: 156 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1039PDF: 1036Suppl. Files: 652HTML: 153 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8131PDF: 4311HTML: 7519 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2245PDF: 1184HTML: 2599Study of serum haptoglobin level in thalassemia: 368Figures: 193 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
920PDF: 708HTML: 327 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3461PDF: 1320HTML: 1923Fig.1: 223Fig. 2: 221







